GSK-3β inhibitor 11
GSK-3β inhibitor 11 (compound 21) is a glycogen synthase kinase-3β (GSK-3β) inhibitor (IC50=10.02 μM) . GSK-3β inhibitor 11 can be used in neurodegenerative disease research[1].
Product Specifications
CAS Number
[536731-65-4]
UNSPSC
12352005
Hazard Statement
H302-H315-H319
Target
GSK-3
Type
Reference compound
Related Pathways
PI3K/Akt/mTOR; Stem Cell/Wnt
Applications
Neuroscience-Neurodegeneration
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/gsk-3β-inhibitor-11.html
Purity
98.02
Solubility
DMSO : 20.83 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
O=C1C2=C(C(N1CC(NC3=NC(C4=CC(OC)=CC=C4)=CS3)=O)=O)C=CC=C2
Molecular Formula
C20H15N3O4S
Molecular Weight
393.42
Precautions
P264-P270-P280-P302+P352-P305+P351+P338-P330-P362+P364-P501
References & Citations
[1]Fu G, et al. Pharmacophore Modeling, Ensemble Docking, Virtual Screening, and Biological Evaluation on Glycogen Synthase Kinase-3β. Mol Inform. 2014 Sep;33 (9) :610-26.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C, 3 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
GSK-3β
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
K4520103 1.0 µg DNA
Rab22a sgRNA CRISPR Lentivector (Mouse) (Target 2)
Sign In for Pricing
View Details 
LV664712 1.0 µg DNA
B4GALT6 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV-C-term-HA)
Sign In for Pricing
View Details